In this episode and the accompanying feature, we invited a patient with lived experience to see if this worked in real life while discussing the potential mechanisms with a researcher.
Product Life Cycles Phase-Appropriate Controls: Each phase of a product life cycle requires a different level of control
Side Effects and Behavioral Outcomes Following High-Dose Carnitine Supplementation Among Young Males With Autism Spectrum Disorder: A Pilot Study
Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation
found that fast escalation to 8 mg produced GI adverse events in 50% of participants, compared to roughly 35% with gradual titration (Rosenstock et al., Lancet, 2023)
The May 2026 Regulatory Environment: What Changed and What It Means for Eden Patients Anyone evaluating a compounded GLP-1 program in May 2026 is making that decision against a regulatory backdrop that has shifted dramatically from 2022, when compounded semaglutide and tirzepatide first became widely available through telehealth platforms